Neoadjuvant MEDI 4736 +/- Tremelimumab in Locally Advanced Renal Cell Carcinoma
Clinical trial NCT02762006 · COMPLETED
Trial details
- NCT number
- NCT02762006
- Sponsor
- Moshe Ornstein
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-20
- Primary completion
- 2020-11-06
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.